ASH 2017 CLL News

Patient Power was on-site at the 2017 American Society of Hematology (ASH) meeting in Atlanta to bring you the latest CLL treatment and research news.

Email this program

Get Link

Innovative Treatment Strategies for CLL: How Can Patients Become MRD Negative?

Is MRD negative status the treatment goal for CLL? How can patients with unique conditions reach it? CLL expert Dr. Nicole Lamanna discusses different approaches to therapy with novel agents.

Published:

Genetic Testing: What Version of CLL Do I Have and How Do I Treat It?

What do doctors look for in genetic tests for CLL patients? How do the results affect the course of treatment? Find out now from CLL expert Dr. Jennifer Brown.

Published:

Post-FCR: Will Novel Treatments Still Work for My CLL?

CLL experts Dr. Jennifer Brown and Dr. William Wierda joined us at ASH 2017 to discuss the effectiveness of novel agents after an FCR treatment regimen. Watch now to find out more.

Published:

BTK Inhibitor Update From ASH 2017: What Are the Real-World Results?

How effective are BTK inhibitors? Do patients tolerate them well in the real world? Dr. Antony Mato and Dr. Jennifer Brown discuss the latest news on the use of BTK inhibitors for CLL patients at ASH 2017.

Published:

CLL Combination Therapy News From ASH 2017

What new combination therapies for CLL were presented at ASH 2017? Tune in to learn the latest with CLL expert Dr. Michael Choi.

Published:

ASH 2017 Roundtable: CLL Research News and Updates From an Expert Panel

Andrew Schorr hosts an expert roundtable to discuss CLL news from the 2017 American Society of Hematology (ASH) meeting in Atlanta.

Published:

ASH 2017 Daily Wrap: Day Three

In day three of Patient Power’s daily wrap-up from the 2017 ASH meeting in Atlanta, Andrew and Esther Schorr are joined by a panel of experts.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 11, 2018